top of page
詢問您的醫師
Tempus Announces Six Abstracts Accepted for Poster Presentation at the 2022 SABCS
KEYWORD: Oncology、SABCS
TEMPUS
2022年12月6日讀畢需時 2 分鐘
Tempus Announces Six Abstracts Accepted for Presentation at the 2022 SITC Annual Meeting
KEYWORD: Oncology、SITC
TEMPUS
2022年11月9日讀畢需時 2 分鐘
Tempus Announces Six Abstracts Accepted for Presentation at the ASCO 2022
KEYWORD: Oncology、ASCO
TEMPUS
2022年11月4日讀畢需時 3 分鐘
Tempus Announces Real-World Data-Driven Program to Accelerate Precision Oncology Research
KEYWORD: AI、DATA、Genomic Sequencing
TEMPUS
2022年10月27日讀畢需時 2 分鐘
GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D
KEYWORD: AI、Genomic Sequencing、GSK
TEMPUS
2022年10月18日讀畢需時 3 分鐘
Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics
KEYWORD: Genomic Sequencing、Clinical Trial、TP53WT
TEMPUS
2022年10月6日讀畢需時 2 分鐘
Tempus Announces Collaboration with the COG to Expand Access to Genomic Testing
KEYWORD: Genomic Sequencing、Clinical Trial
TEMPUS
2022年9月20日讀畢需時 2 分鐘
Tempus Announces Three Abstracts Accepted For Presentation at the ESMO
KEYWORD: Oncology、ESMO
TEMPUS
2022年9月9日讀畢需時 3 分鐘
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology
KEYWORD: DATA、Genomic Sequencing
TEMPUS
2022年6月16日讀畢需時 2 分鐘
Tempus Announces Sequencing Collaboration with Lilly to Expand Access to Genomic Testing
KEYWORD: Genomic Sequencing
TEMPUS
2022年6月9日讀畢需時 2 分鐘
Tempus CE Marks Its Broad-Panel Genomic Sequencing and Algorithmic Diagnostic Tests
KEYWORD: AI、Genomic Sequencing
TEMPUS
2022年6月7日讀畢需時 3 分鐘
Tempus Announces 14 Abstracts Accepted For Presentation at the American Society of Clinical Oncology
KEYWORD: AI、Clinical Trials、DATA、Genomic Sequencing
TEMPUS
2022年6月6日讀畢需時 3 分鐘
Tempus to Launch Largest Clinically Available Liquid Biopsy Panel, xF+
KEYWORD: Genomic Sequencing、Product Launch
TEMPUS
2022年6月3日讀畢需時 2 分鐘
Tempus Announces Agreement With the United States Department of Veterans Affairs National Precision
KEYWORD: AI、Genomic Sequencing
TEMPUS
2022年5月6日讀畢需時 2 分鐘
Tempus Announces Abstracts Accepted For Presentation at the American Association for Cancer Researc
KEYWORD: AI、Genomic Sequencing
TEMPUS
2022年4月8日讀畢需時 2 分鐘
Tempus’ Edge Platform Leverages Data & AI to Identify Therapeutic Options for Patients Earlier in th
KEYWORD: AI、DATA、Product Launch
TEMPUS
2022年3月21日讀畢需時 2 分鐘
Tempus Announces the Acquisition of Highline Sciences
KEYWORD: Clinical Trials
TEMPUS
2022年2月8日讀畢需時 2 分鐘
Tempus Announces Open Enrollment for Study in Collaboration with GSK to Evaluate Niraparib in Advan
KEYWORD: Clinical Trials、Solid Tumor、Genomic Sequencing、Germline
TEMPUS
2022年1月13日讀畢需時 2 分鐘
Tempus Announces Agreement with Janssen R&D to Leverage AI/ML and Real-World Evidence to Enhance the
KEYWORD: Clinical Trials、Genomic Sequencing
TEMPUS
2021年12月1日讀畢需時 2 分鐘
Tempus Signs Strategic Collaboration Agreement with AstraZeneca to Advance Oncology Therapeutics
KEYWORD: AstraZeneca
TEMPUS
2021年11月19日讀畢需時 2 分鐘
bottom of page